Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank86
5Y CAGR+15.6%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+15.6%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 38.65% |
| 2024 | 132.22% |
| 2023 | 63.60% |
| 2022 | -2.75% |
| 2021 | 16.42% |
| 2020 | 18.76% |
| 2019 | 7.52% |
| 2018 | 25.61% |
| 2017 | -143.00% |
| 2016 | -39.45% |